{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:51:44Z","timestamp":1740135104518,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GY1145"],"award-info":[{"award-number":["01GY1145"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12913-019-4372-y","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T14:02:27Z","timestamp":1564668147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices \u2013 results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment)"],"prefix":"10.1186","volume":"19","author":[{"given":"Cornelia","family":"Mertens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Siebenhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Berghold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudrun","family":"Pregartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa-Rebekka","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karola","family":"Mergenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Kemperdick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Schulz-Rothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Rauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Harder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand Michael","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Johanna","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"4372_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/CLEP.S47385","volume":"6","author":"M Zoni-Berisso","year":"2014","unstructured":"Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213\u201320.","journal-title":"Clin Epidemiol"},{"issue":"6 Suppl","key":"4372_CR2","doi-asserted-by":"publisher","first-page":"160S","DOI":"10.1378\/chest.08-0670","volume":"133","author":"J Ansell","year":"2008","unstructured":"Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(6 Suppl):160S\u201398S.","journal-title":"Chest"},{"key":"4372_CR3","doi-asserted-by":"crossref","unstructured":"Schwabe U, Paffrath D, Ludwig W-D, Klauber J. Arzneiverordnungs-Report 2017 [drug prescription report 2017]. Berlin; Heidelberg: Springer; 2017. Available from: https:\/\/ebookcentral.proquest.com\/lib\/gbv\/detail.action?docID=5113054 .","DOI":"10.1007\/978-3-662-54630-7"},{"issue":"9","key":"4372_CR4","first-page":"807","volume":"13","author":"SV Garkina","year":"2016","unstructured":"Garkina SV, Vavilova TV, Lebedev DS, Mikhaylov EN. Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants. J Geriatr Cardiol. 2016;13(9):807\u201310.","journal-title":"J Geriatr Cardiol"},{"key":"4372_CR5","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft. Leitfaden \u201cOrale Antikoagulation bei nicht valvul\u00e4rem Vorhofflimmern\u201d (2. \u00fcberarbeitete Auflage). [Drug commission of the German medical profession. Guideline \u201cOral anticoagulation in non-valvular atrial fibrillation\u201d (2nd revised edition)]; 2016."},{"issue":"11","key":"4372_CR6","doi-asserted-by":"publisher","first-page":"e013263","DOI":"10.1136\/bmjopen-2016-013263","volume":"6","author":"A Holbrook","year":"2016","unstructured":"Holbrook A, Dormuth C, Morrow R, Lee A, Troyan S, Li G, et al. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol. BMJ Open. 2016;6(11):e013263.","journal-title":"BMJ Open"},{"issue":"11","key":"4372_CR7","first-page":"997","volume":"60","author":"J Douketis","year":"2014","unstructured":"Douketis J, Bell AD, Eikelboom J, Liew A. Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions. Can Fam Physician. 2014;60(11):997\u20131001.","journal-title":"Can Fam Physician"},{"issue":"16","key":"4372_CR8","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, et al. The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330\u201393.","journal-title":"Eur Heart J"},{"key":"4372_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/TCRM.S84210","volume":"11","author":"YH Mekaj","year":"2015","unstructured":"Mekaj YH, Mekaj AY, Duci SB, Miftari EI. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015;11:967\u201377.","journal-title":"Ther Clin Risk Manag"},{"issue":"12","key":"4372_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have Nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857.","journal-title":"Ann Intern Med"},{"issue":"11","key":"4372_CR11","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1503\/cmaj.061523","volume":"176","author":"N Oake","year":"2007","unstructured":"Oake N, Fergusson DA, Forster AJ, van Walraven C. Frequency of adverse events in patients with poor anticoagulation: a meta-analysis. CMAJ. 2007;176(11):1589\u201394.","journal-title":"CMAJ"},{"issue":"3","key":"4372_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1001\/archinte.167.3.239","volume":"167","author":"HD White","year":"2007","unstructured":"White HD, Gruber M, Feyzi J, Kaatz S, Tse H-F, Husted S, et al. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med. 2007;167(3):239\u201345.","journal-title":"Arch Intern Med"},{"key":"4372_CR13","doi-asserted-by":"crossref","unstructured":"Szummer K, Gasparini A, Eliasson S, \u00c4rnl\u00f6v J, Qureshi AR, B\u00e1r\u00e1ny P, et al. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction. J Am Heart Assoc. 2017;6(3).","DOI":"10.1161\/JAHA.116.004925"},{"issue":"1","key":"4372_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/europace\/eum223","volume":"10","author":"JS Taggar","year":"2008","unstructured":"Taggar JS, Lip GYH. Anticoagulation for elderly patients with atrial fibrillation: not to be neglected. Europace. 2008;10(1):1\u20132.","journal-title":"Europace"},{"issue":"3","key":"4372_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/archinte.167.3.229","volume":"167","author":"SE Kimmel","year":"2007","unstructured":"Kimmel SE, Chen Z, Price M, Parker CS, Metlay JP, Christie JD, et al. The influence of patient adherence on anticoagulation control with warfarin: results from the international normalized ratio adherence and genetics (IN-RANGE) study. Arch Intern Med. 2007;167(3):229\u201335.","journal-title":"Arch Intern Med"},{"issue":"2","key":"4372_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1024\/0300-9831.76.2.65","volume":"76","author":"R Couris","year":"2006","unstructured":"Couris R, Tataronis G, McCloskey W, Oertel L, Dallal G, Dwyer J, et al. Dietary vitamin K variability affects international normalized ratio (INR) coagulation indices. Int J Vitam Nutr Res. 2006;76(2):65\u201374.","journal-title":"Int J Vitam Nutr Res"},{"key":"4372_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1748-5908-7-79","volume":"7","author":"A Siebenhofer","year":"2012","unstructured":"Siebenhofer A, Ulrich LR, Mergenthal K, Roehl I, Rauck S, Berghold A, et al. Primary care management for optimized antithrombotic treatment PICANT: study protocol for a cluster-randomized controlled trial. Implement Sci. 2012;7:79.","journal-title":"Implement Sci"},{"issue":"1","key":"4372_CR18","doi-asserted-by":"publisher","first-page":"e0209366","DOI":"10.1371\/journal.pone.0209366","volume":"14","author":"A Siebenhofer","year":"2019","unstructured":"Siebenhofer A, Ulrich L-R, Mergenthal K, Berghold A, Pregartner G, Kemperdick B, et al. Primary care management for patients receiving long-term antithrombotic treatment: a cluster-randomized controlled trial. PLoS One. 2019;14(1):e0209366.","journal-title":"PLoS One"},{"issue":"4","key":"4372_CR19","first-page":"165","volume":"89","author":"L-R Ulrich","year":"2013","unstructured":"Ulrich L-R, Petersen JJ, Mergenthal K, Roehl I, Rauck S, Erler A, et al. Eine Monitoring-Liste f\u00fcr ein haus\u00e4rztliches Case Management bei oraler Antikoagulation. [A monitoring list for oral anticoagulation case management in primary care]. Z Allg Med. 2013;89(4):165\u201371.","journal-title":"Z Allg Med"},{"key":"4372_CR20","doi-asserted-by":"crossref","unstructured":"EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 1990; 16(3):199\u2013208.","DOI":"10.1016\/0168-8510(90)90421-9"},{"issue":"2","key":"4372_CR21","first-page":"e55","volume":"18","author":"K Goetz","year":"2012","unstructured":"Goetz K, Freund T, Gensichen J, Miksch A, Szecsenyi J, Steinhaeuser J. Adaptation and psychometric properties of the PACIC short form. Am J Manag Care. 2012;18(2):e55\u201360.","journal-title":"Am J Manag Care"},{"issue":"1","key":"4372_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67\u201374.","journal-title":"Med Care"},{"key":"4372_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2296-12-17","volume":"12","author":"TD Hua","year":"2011","unstructured":"Hua TD, Vormfelde SV, Abu Abed M, Schneider-Rudt H, Sobotta P, Friede T, et al. Practice nursed-based, individual and video-assisted patient education in oral anticoagulation--protocol of a cluster-randomized controlled trial. BMC Fam Pract. 2011;12:17.","journal-title":"BMC Fam Pract"},{"issue":"8","key":"4372_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.282.8.737","volume":"282","author":"M Man-Son-Hing","year":"1999","unstructured":"Man-Son-Hing M, Laupacis A, O'Connor AM, Biggs J, Drake E, Yetisir E, et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial. JAMA. 1999;282(8):737\u201343.","journal-title":"JAMA"},{"issue":"3","key":"4372_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","volume":"69","author":"FR Rosendaal","year":"1993","unstructured":"Rosendaal FR, Cannegieter SC, van der Meer FJ, Bri\u00ebt E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236\u20139.","journal-title":"Thromb Haemost"},{"issue":"1","key":"4372_CR26","first-page":"50","volume":"70","author":"P Kirchhof","year":"2017","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the Management of Atrial Fibrillation Developed in collaboration with EACTS. Rev Esp Cardiol (Engl Ed). 2017;70(1):50.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"12","key":"4372_CR27","doi-asserted-by":"publisher","first-page":"e0144314","DOI":"10.1371\/journal.pone.0144314","volume":"10","author":"A Tosetto","year":"2015","unstructured":"Tosetto A, Manotti C, Marongiu F. Center-related determinants of VKA anticoagulation quality: a prospective. Multicenter Evaluation PLoS ONE. 2015;10(12):e0144314.","journal-title":"Multicenter Evaluation PLoS ONE"},{"key":"4372_CR28","unstructured":"IBM Corp. Released 2017. IBM SPSS statistics for Macintosh, version 25.0. Armonk: IBM Corp."},{"key":"4372_CR29","unstructured":"R: A Language and Environment for Statistical Computing. Version 3.4.4. Vienna, Austria: R Foundation for Statistical Computing; 2018. Available from: URL: www.R-project.org ."},{"key":"4372_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12875-014-0170-0","volume":"15","author":"L-R Ulrich","year":"2014","unstructured":"Ulrich L-R, Mergenthal K, Petersen JJ, Roehl I, Rauck S, Kemperdick B, et al. Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial. BMC Fam Pract. 2014;15:170.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"4372_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12875-017-0588-2","volume":"18","author":"V Maikranz","year":"2017","unstructured":"Maikranz V, Siebenhofer A, Ulrich L-R, Mergenthal K, Schulz-Rothe S, Kemperdick B, et al. Does a complex intervention increase patient knowledge about oral anticoagulation? - a cluster-randomised controlled trial. BMC Fam Pract. 2017;18(1):15.","journal-title":"BMC Fam Pract"},{"issue":"37","key":"4372_CR32","first-page":"607","volume":"111","author":"SV Vormfelde","year":"2014","unstructured":"Vormfelde SV, Abu Abed M, Hua TD, Schneider S, Friede T, Chenot J-F. Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice. Dtsch Arztebl Int. 2014;111(37):607\u201314.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"4372_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejim.2013.12.013","volume":"25","author":"S Mueller","year":"2014","unstructured":"Mueller S, Pfannkuche M, Breithardt G, Bauersachs R, Maywald U, Kohlmann T, et al. The quality of oral anticoagulation in general practice in patients with atrial fibrillation. Eur J Intern Med. 2014;25(3):247\u201354.","journal-title":"Eur J Intern Med"},{"key":"4372_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12916-015-0268-9","volume":"13","author":"JH Prochaska","year":"2015","unstructured":"Prochaska JH, G\u00f6bel S, Keller K, Coldewey M, Ullmann A, Lamparter H, et al. Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVAL. BMC Med. 2015;13:14.","journal-title":"BMC Med"},{"issue":"3","key":"4372_CR35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.18553\/jmcp.2009.15.3.244","volume":"15","author":"WL Baker","year":"2009","unstructured":"Baker WL, Cios DA, Sander SD, Coleman CI. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm. 2009;15(3):244\u201352.","journal-title":"J Manag Care Pharm"},{"issue":"18","key":"4372_CR36","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1093\/eurheartj\/ehr134","volume":"32","author":"M Wieloch","year":"2011","unstructured":"Wieloch M, Sj\u00e4lander A, Frykman V, Rosenqvist M, Eriksson N, Svensson PJ. Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA. Eur Heart J. 2011;32(18):2282\u20139.","journal-title":"Eur Heart J"},{"issue":"5","key":"4372_CR37","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/1076029615623378","volume":"23","author":"C Tajer","year":"2017","unstructured":"Tajer C, Ceresetto J, Bottaro FJ, Mart\u00ed A, Casey M. Assessment of the quality of chronic anticoagulation control with time in therapeutic range in atrial fibrillation patients treated with vitamin K antagonists by hemostasis specialists: the TERRA registry: Tiempo en rango en la Rep\u00fablica Argentina. Clin Appl Thromb Hemost. 2017;23(5):445\u201353.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"4372_CR38","first-page":"226","volume":"80","author":"T K\u00fchlein","year":"2018","unstructured":"K\u00fchlein T, Madlo-Thiess F, Wambach V, Schaffer S. Zehn Jahre Qualit\u00e4tsmanagement: Wahrnehmung und Stellenwert aus Sicht von Haus\u00e4rzten in einem \u00c4rztenetz. [10 years of quality management: perception and importance from GPs\u2019 point of view]. Gesundheitswesen. 2018;80(3):226\u201331.","journal-title":"Gesundheitswesen"},{"issue":"4","key":"4372_CR39","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/bjh.14273","volume":"175","author":"C Schaefer","year":"2016","unstructured":"Schaefer C, Wuillemin WA, Kessels A, Jacobson A, Nagler M. Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with vitamin K antagonists in real-life practice: a survey of the international self-monitoring Association of Orally Anticoagulated Patients. Br J Haematol. 2016;175(4):677\u201385.","journal-title":"Br J Haematol"},{"issue":"5","key":"4372_CR40","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1378\/chest.13-0054","volume":"144","author":"S Apostolakis","year":"2013","unstructured":"Apostolakis S, Sullivan RM, Olshansky B, Lip GYH. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score. Chest. 2013;144(5):1555\u201363.","journal-title":"Chest"},{"issue":"9","key":"4372_CR41","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/europace\/eux314","volume":"20","author":"MA Esteve-Pastor","year":"2018","unstructured":"Esteve-Pastor MA, Rivera-Caravaca JM, Rold\u00e1n-Rabad\u00e1n I, Rold\u00e1n V, Mu\u00f1iz J, Ra\u00f1a-M\u00edguez P, et al. Quality of oral anticoagulation with vitamin K antagonists in \u2018real-world\u2019 patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry. Europace. 2018;20(9):1435\u201341.","journal-title":"Europace"},{"issue":"6","key":"4372_CR42","first-page":"83","volume":"111","author":"A Siebenhofer","year":"2014","unstructured":"Siebenhofer A, Jeitler K, Horvath K, Habacher W, Schmidt L, Semlitsch T. Self-management of oral anticoagulation. Dtsch Arztebl Int. 2014;111(6):83\u201391.","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"4372_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00392-005-0199-0","volume":"94","author":"H V\u00f6ller","year":"2005","unstructured":"V\u00f6ller H, Glatz J, Taborski U, Bernardo A, Dovifat C, Heidinger K. Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Z Kardiol. 2005;94(3):182\u20136.","journal-title":"Z Kardiol"},{"issue":"6","key":"4372_CR44","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/j.1538-7836.2007.02561.x","volume":"5","author":"DJ Meier","year":"2007","unstructured":"Meier DJ, Seva S, Fay WP. A comparison of anticoagulation results of patients managed with narrow vs. standard international normalized ratio target ranges. J Thromb Haemost. 2007;5(6):1332\u20134.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"4372_CR45","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11239-016-1446-0","volume":"43","author":"A Zirlik","year":"2017","unstructured":"Zirlik A, Bode C. Vitamin K Antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation. J Thromb Thrombolysis. 2017;43(3):365\u201379.","journal-title":"J Thromb Thrombolysis"},{"key":"4372_CR46","unstructured":"arznei-telegramm. Vohrhofflimmern: Neue orale Antikoagulanzien in der \u201erealen Welt\u201c. [Atrial fibrillation: New oral anticoagulants in the \u201ereal world\u201c]. 2018."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-019-4372-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-019-4372-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-019-4372-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T20:05:20Z","timestamp":1610741120000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-019-4372-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4372"],"URL":"https:\/\/doi.org\/10.1186\/s12913-019-4372-y","relation":{},"ISSN":["1472-6963"],"issn-type":[{"type":"electronic","value":"1472-6963"}],"subject":[],"published":{"date-parts":[[2019,8,1]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee (E 191\/11) of the Department of Medicine of the University of Frankfurt am Main (\u201cEthik-Kommission des Fachbereichs Medizin der Goethe-Universit\u00e4t Frankfurt am Main\u201d) rated the study with approval on June 26, 2012.Reference number: 404\/11Before the study started, we obtained signed written informed consent from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JJP was co-investigator and KM project manager in the PANORA study (\u2018Prevalence of anti-cyclic citrullinated peptide (CCP) positivity in patients with new non-specific onset of musculoskeletal symptoms, possibly related to early rheumatoid arthritis in general practices in Germany\u2019). The PANORA study was conducted by the Fraunhofer Institute and financed by Bristol-Meyer Squibb. JJP and KM are employed by the Institute of General Practice of Goethe University Frankfurt and have never personally received any financial compensation from a pharmaceutical company. AS carried out a systematic review of the self-management of oral anticoagulation in 2014 with funding from the Federation of Austrian Social Insurance Institutions (HVB). She also received financial support from ROCHE Diagnostics to conduct a study on self-management of oral anticoagulation from 2002 to 2005. SH has received honoraria for scientific lectures from Boehringer Ingelheim GmbH, Pfizer GmbH, Daiichi Sankyo GmbH, and Bayer AG. The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"539"}}